Harnessing Oncolytic Viruses to Surpass the ‘Cold’ Tumor Microenvironment
Time: 2:30 pm
day: Conference Day 2
Details:
- Design of novel oncolytic viruses to inhibit the immunosuppressive microenvironment, expose multiple tumor antigens and selectively kill cancer cells for an individualized immune response
- Evaluate viral immunotherapy showing promise in treatment resistant high-grade glioma
- Review clinical and biomarker data from a phase 1 study of CAN-3110 in recurrent high grade glioma
